- Contract Awards
The U.S. Army has reserved at least 100,000 doses of AstraZeneca’s AZD7442, a long-acting antibody product designed to prevent COVID-19 infection or treat the coronavirus disease, through a $204.9 million contract modification. The service branch obligated the full amount using its fiscal 2021 research, development, test and evaluation funds, ...









